Intranasal Ketamine in Treatment-Resistant Depression
NCT01304147
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Major Depressive Disorder
Interventions
DRUG:
Ketamine
DRUG:
placebo
Sponsor
James Murrough